...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Notice of Meeting and Management Information Circular Posted

I didn't see anything revealing here. Anyone else? Meeting 2 PM Calgary time following Resverlogix meeting at 1 PM on October 31st.

BDAZ

Share
New Message
Please login to post a reply